- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity
Kevin J Fagan1,2,
Carel J Pretorius3,4,
Leigh U Horsfall1,2,
Katharine M Irvine2,
Urs Wilgen3,4,
Kihoon Choi2,
Linda M Fletcher1,3,
Jill Tate4,
Michelle Melino2,
Sharmin Nusrat2,
Gregory C Miller2,
Andrew D Clouston2,
Emma Ballard5,
Peter O'Rourke5,
Guy Lampe6,
Jacobus PJ Ungerer4 and
Elizabeth E Powell1,2,*
DOI: 10.1111/liv.12760
This article is protected by copyright. All rights reserved.
Vol. 34 Issue 10
Liver International
Author Information
1 Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Australia
2 Centre for Liver Disease Research, School of Medicine, The University of Queensland, Brisbane, Australia
3 School of Medicine, The University of Queensland, Brisbane, Australia
4 Department of Chemical Pathology, Pathology Queensland, Brisbane, Australia
5 Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
6 Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia
* Correspondence to:
Elizabeth Powell, Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba 4102, Queensland, Australia. [email protected], Telephone: +61-7-34438015 Fax: +61-7-34438015
Abstract
Background and Aims
There is increasing need to identify individuals with advanced liver fibrosis, who are at risk of complications such as hepatocellular carcinoma. The commercially available Enhanced Liver Fibrosis (ELF) test provides a non-invasive assessment of fibrosis severity. This study was designed to determine the diagnostic accuracy of the manufacturer's cut-off value (≥9.8) in identifying advanced fibrosis.
Methods
The relationship between ELF score and fibrosis was examined using serum collected at time of liver biopsy for investigation of liver disease, particularly viral hepatitis. Fibrosis was staged using a modified METAVIR score. If available, liver tissue was recut and stained with Sirius red to determine collagen proportional area and subsinusoidal fibrosis.
Results
ELF score ≥9.8 had a sensitivity of 74.4% and specificity 92.4% for detecting advanced fibrosis. In the whole cohort (n=329), ELF score was more likely to incorrectly classify individuals if age was ≥45 years and METAVIR inflammatory grade was 2 or 3 (adjusted OR 3.71 and 2.62 respectively). In contrast, ELF score was less likely to misclassify individuals in the presence of steatosis (OR 0.37). Neither subsinusoidal fibrosis nor collagen proportional area explained the discordance in ELF score for patients with or without advanced fibrosis.
Conclusion
Although ELF score ≥9.8 reliably identifies advanced fibrosis in patients with chronic liver disease, both age and inflammatory activity need to be considered when interpreting the result. Importantly, ELF score performed well in the presence of steatosis and could thus be helpful in the assessment of fatty liver disease.
This article is protected by copyright. All rights reserved.
|
|